Arena BioWorks
Brian Albrecht is an experienced professional in drug discovery and development, currently serving as the PRO Chair of Small Molecule Therapeutics at Arena BioWorks since October 2024. Previously, Albrecht was a Partner and Head of Drug Discovery at Related Sciences from March 2021 to September 2024, where efforts focused on data-driven approaches and machine learning for drug discovery. Albrecht has also held roles such as VP of Drug Discovery at Rheos Medicines from March 2018 to August 2020, Principal and Strategic Advisor at Third Rock Ventures from July 2015 to March 2018, and various positions at Constellation Pharmaceuticals and Amgen, including Senior Director and Senior Scientist. Albrecht earned a Ph.D. in Chemistry from Colorado State University and a BS in Chemistry from Lafayette College.
This person is not in any teams
Arena BioWorks
Arena BioWorks is a biomedical research institute focused on uncovering the mechanisms of human disease to identify opportunities for therapeutic intervention. The Institute's private funding model allows Arena to advance novel therapeutics by forming and supporting biotech companies up to early clinical / Series B stage. To learn more, visit arenabioworks.com.